We identified that TP53 (51.4%), LRP1B (13.4%), PIK3CA (11.6%), KRAS (11.1%), EGFR (10.6%), and APC (10.5%) are the top mutated cancer genes in Chinese cancer patients. This evidence concerns the gene TP53 and cancer.